aTyr Pharma, Inc. (LIFE) Financials
Stock symbol LIFE is outdated, potentially delisted? Maybe it is available on other exchange?
LIFE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2024 | 113.3 million | 29.0 million |
| Dec. 31, 2023 | 122.1 million | 31.6 million |
| Sept. 30, 2023 | 125.1 million | 26.9 million |
| June 30, 2023 | 132.7 million | 26.7 million |
LIFE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2024 | -22.4 million | 740000 |
| Dec. 31, 2023 | -11.1 million | 659000 |
| Sept. 30, 2023 | -10.1 million | 664000 |
| June 30, 2023 | -14.4 million | 658000 |
LIFE Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2024 | -15.5 million |
| Dec. 31, 2023 | -14.8 million |
| Sept. 30, 2023 | -11.3 million |
| June 30, 2023 | -12.3 million |
LIFE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2024 | 84.5 million | 13.0 million | 13.0 million |
| Dec. 31, 2023 | 98.2 million | 13.8 million | 13.8 million |
| Sept. 30, 2023 | 105.6 million | 14.0 million | 15.2 million |
| June 30, 2023 | 108.6 million | 14.3 million | 15.4 million |
LIFE Shares Outstanding
LIFE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2024 | 17000 | 13.4 million | 2.7 million | -770000 |
| Dec. 31, 2023 | 17000 | 12.8 million | 2.8 million | -407000 |
| Sept. 30, 2023 | 557000 | 10.3 million | 2.6 million | - |
| June 30, 2023 | 2.4 million | 9.8 million | 3.7 million | - |
LIFE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2024 | 235000 | 770000 |
| Dec. 31, 2023 | 4.3 million | 407000 |
| Sept. 30, 2023 | 353000 | 993000 |
| June 30, 2023 | - | 586000 |
LIFE Revenue by Segment
Graph available only for paid members. Upgrade to see it.
LIFE
Price: $1.90
52 week price:
Earnings Per Share: -0.88 USD
P/E Ratio: -1.77
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 171300
Ebitda: -10.7 millionMarket Capitalization: 131.1 million